Nevro LLC

Nevro Corp. engages in the development of medical devices. The company is headquartered in Redwood City, California and currently employs 1,099 full-time employees. The firm is focused on delivering solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. Its product portfolio includes both spinal cord stimulation (SCS) treatment therapy for certain forms of neuropathic pain and minimally invasive treatment options for patients suffering from chronic sacroiliac (SI) joint pain. The firm has developed and commercialized its HFX SCS platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain, with the Senza HFX iQ platform being its latest addition to the Senza family of products. Its HFX Therapy and 10 kHz Therapy are designed to deliver neuromodulation solutions for treating chronic pain. Its products include Senza II SCS System, Senza Omnia SCS System, Senza Omnia upgrade, Omnia Powered by HFX Connect, PDN Indication Approval, NSBP Approval, Senza HFX iQ System, and others.